share_log

復宏漢霖:自願公告 - 帕妥珠單抗生物類似藥HLX11(重組抗HER2結構域II人源化單克隆抗體注射液)的上市註冊申請(NDA)獲國家藥品監督管理局(NMPA)受理

HENLIUS: VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION (NDA) FOR PERTUZUMAB BIOSIMILARHLX11 (RECOMBINANT ANTI-HER2 DOMAIN II HUMANIZEDMONOCLONAL ANTIBODY INJECTION) HAS BEEN ACCEPTED BY THENATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA)

HKEX ·  Dec 4, 2024 17:48
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more